Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.2770
-0.0030 (-1.07%)
Oct 3, 2025, 3:39 PM EDT
Integrated BioPharma Revenue
In the fiscal year ending June 30, 2025, Integrated BioPharma had annual revenue of $54.35M with 8.02% growth. Integrated BioPharma had revenue of $14.18M in the quarter ending June 30, 2025, with 11.21% growth.
Revenue
54.35M
Revenue Growth
+8.02%
P/S Ratio
0.16
Revenue / Employee
355.25K
Employees
153
Market Cap
8.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 54.35M | 4.04M | 8.02% |
| Jun 30, 2024 | 50.32M | -355.00K | -0.70% |
| Jun 30, 2023 | 50.67M | -5.57M | -9.91% |
| Jun 30, 2022 | 56.25M | -7.31M | -11.51% |
| Jun 30, 2021 | 63.56M | 10.79M | 20.45% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cordyceps Sunshine Biotech Holdings | 1.25M |
| Microalliance Group | 22.88M |
| Cuisine Solutions | 80.48M |
| Armanino Foods of Distinction | 73.15M |
| South Dakota Soybean Processors, LLC | 485.00M |
| ESG Inc. | 11.87M |
| Crimson Wine Group | 71.27M |
| Charlie's Holdings | 8.25M |
Integrated BioPharma News
- 11 days ago - Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 - Accesswire
- 5 months ago - Integrated BioPharma GAAP EPS of $0.02, revenue of $13.9M - Seeking Alpha
- 5 months ago - Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 - Accesswire
- 8 months ago - Integrated BioPharma GAAP EPS of $0.00, revenue of $12.6M - Seeking Alpha
- 8 months ago - Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 - Accesswire
- 11 months ago - Integrated BioPharma GAAP EPS of $0.01, revenue of $13.6M - Seeking Alpha
- 11 months ago - Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 - Accesswire
- 1 year ago - Integrated BioPharma reports Q4 results - Seeking Alpha